QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Prados, M. D. Articles by Schold, S. C. Search for Related Content PubMed PubMed Citation

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

Departments of Neurological Surgery (M.D.P., S.M.C.) and Neuro-Oncology (M.K.N.), University of California at San Francisco, San Francisco, CA 94143; Departments of Neuro-Oncology (W.K.A.Y.) and Biostatistics (K.R.H.), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD 20892 (H.A.F.); Department of Neurology, University of Michigan, Ann Arbor, MI 48109 (H.S.G., L.J.); Departments of Medicine (H.I.R.) and Radiotherapy (M.P.M.), University of Wisconsin, Madison, WI 53792; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 (K.L.F.); Departments of Neurology and Hematology/Oncology, Mayo Clinic Jacksonville, Jacksonville, FL 32224 (K.A.J.); College of Pharmacy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 (J.K.); Office of Clinical Research, University of Pittsburgh, Pittsburgh, PA 15261 (S.C.S.); USA

² Address correspondence to Michael Prados, University of California at San Francisco, 400 Parnassus Avenue, Room A808, San Francisco, CA 94143, USA (pradosm{at}neurosurg.ucsf.edu).

References

Fine, H.A. (1994) The basis for current treatment recommendations for malignant gliomas. J. Neurooncol. 20,111 -120.[CrossRef][Medline]

Friedman, H.S., Johnson, S.P., Dong, Q., Schold, S.C., Rasheed, B.K., Bigner, S.H., Ali-Osman, F., Dolan, E., Colvin, O.M., Houghton, P., Germain, G., Drummond, J.T., Keir, S., Marcelli, S., Bigner, D.D., and Modrich, P. (1997) Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft [erratum in Cancer Res. 57, 4973, 1997] Cancer Res. 57,2933 -2936.[Abstract/Free Full Text]

Hammond L.A., Eckardt, J.R., Kuhn, J., Rizzo, J., Johnson, T., Villalona-Calero, M., Tolcher, A., Von Hoff, D.D., and Rowinsky, E.K. (2000) A phase I and pharmacokinetic (PK) trial of 2 sequences of BCNU and temozolomide in patients with advanced solid tumors. Neuro-Oncol. 2,267 (abstract 90).

Huncharek, M., and Muscat, J. (1998) Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res. 18,1303 -1311.[ISI][Medline]

NCI. National Cancer Institute (1999) Common Toxicity Criteria version 2.0. Available at https://webapps.ctep.nci.nih.gov/ctcv2/plsql/ctc000w$.startup.

Plowman, J., Waud, W.R., Koutsoukos, A.D., Rubinstein, L.V., Moore, T.D., and Grever, M.R. (1994) Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 54,3793 -3799.[Abstract/Free Full Text]

Rich, J., Reardon, D., Allen, D., Affronti, M., Carter, J., Edwards, S., Friedman, A., Gururangan, S., Herndon, J., Jackson, S., McLendon, R., Quinn, J., Tourt-Uhlig, S., Sampson, J., Bigner, D., Stafford-Fox, V., Zaknoen, S., and Friedman, H. (2001) Phase I/II trial of Gliadel plus Temodar for adult patients with recurrent high-grade glioma. Proc. Am. Soc. Clin. Oncol. 20, 75b (abstract 2051).

Schold, S.C. Jr., Kuhn, J.G., Chang, S.M., Bosik, M.E., Robins, H.I., Mehta, M.P., Spence, A.M., Fulton, D., Fink, K.L., and Prados, M.D. (2000) A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Tumor Consortium study. Neuro-Oncol. 2,34 -39.[Abstract]

Stevens, M.F., and Newlands, E.S. (1993) From triazines and triazenes to temozolomide. Eur. J. Cancer 29A,1045 -1047.[CrossRef]

Wong, E.T., Hess, K.R., Gleason, M.J., Jaeckle, K.A., Kyritsis, A.P., Prados, M.D., Levin, V.A., and Yung, W.K. (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J. Clin. Oncol. 17, 2572.[Abstract/Free Full Text]

Yung, W.K., Prados, M.D., Yaya-Tur, R., Rosenfeld, S.S., Brada, M., Friedman, H.S., Albright, R., Olson, J., Chang, S.M., O'Neill, A.M., Friedman, A.H., Bruner, J., Yue, N., Dugan, M., Zaknoen, S., and Levin, V.A. (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J. Clin. Oncol. 17,2762 -2771.[Abstract/Free Full Text]

Yung, W.K., Albright, R.E., Olson, J., Fredericks, R., Fink, K., Prados, M.D., Brada, M., Spence, A., Hohl, R.J., Shapiro, W., Glantz, M., Greenberg, H., Selker, R.G., Vick, N.A., Rampling, R., Friedman, H., Phillips, P., Bruner, J., Yue, N., Osoba, D., Zaknoen, S., and Levin, V.A. (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer 83,588 -593.[CrossRef][ISI][Medline]

This article has been cited by other articles:

				R. I. Jakacki, A. Yates, S. M. Blaney, T. Zhou, R. Timmerman, A. M. Ingle, L. Flom, M. D. Prados, P. C. Adamson, and I. F. Pollack A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood Neuro-oncol, August 1, 2008; 10(4): 569 - 576. [Abstract] [Full Text] [PDF]

				S. M. Chang, K. R. Lamborn, J. G. Kuhn, W.K. A. Yung, M. R. Gilbert, P. Y. Wen, H. A. Fine, M. P. Mehta, L. M. DeAngelis, F. S. Lieberman, et al. Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium Neuro-oncol, August 1, 2008; 10(4): 631 - 642. [Abstract] [Full Text] [PDF]

				U. Herrlinger, J. Rieger, D. Koch, S. Loeser, B. Blaschke, R.-D. Kortmann, J. P. Steinbach, T. Hundsberger, W. Wick, R. Meyermann, et al. Phase II Trial of Lomustine Plus Temozolomide Chemotherapy in Addition to Radiotherapy in Newly Diagnosed Glioblastoma: UKT-03 J. Clin. Oncol., September 20, 2006; 24(27): 4412 - 4417. [Abstract] [Full Text] [PDF]

				G. D. Shah, S. Kesari, R. Xu, T. T. Batchelor, A. M. O'Neill, F. H. Hochberg, B. Levy, J. Bradshaw, and P. Y. Wen Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas Neuro-oncol, January 1, 2006; 8(1): 38 - 46. [Abstract] [Full Text] [PDF]

				J. A. Quinn, A. Desjardins, J. Weingart, H. Brem, M. E. Dolan, S. M. Delaney, J. Vredenburgh, J. Rich, A. H. Friedman, D. A. Reardon, et al. Phase I Trial of Temozolomide Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma J. Clin. Oncol., October 1, 2005; 23(28): 7178 - 7187. [Abstract] [Full Text] [PDF]

				M. Barrie, C. Couprie, H. Dufour, D. Figarella-Branger, X. Muracciole, K. Hoang-Xuan, D. Braguer, P. M. Martin, J. C. Peragut, F. Grisoli, et al. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme Ann. Onc., July 1, 2005; 16(7): 1177 - 1184. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Prados, M. D. Articles by Schold, S. C. Search for Related Content PubMed PubMed Citation